Open access · US-GOV
via ClinicalTrials.gov Clinical trial
SARCOPEDIA - Sarcopenia Diagnostics in Aging Medicine
Authors not listed
University Department of Geriatric Medicine FELIX PLATTER · 2022
Abstract
Musculoskeletal aging is one of the major responsibilities and challenges for public health. In particular, sarcopenia correlates with an increased risk of falls and increased morbidity and mortality. With regard to screening for sarcopenia, the guidelines of the European Working Group on Sarcopenia in Older People (EWGSOP2) refer to algorithmic case finding, diagnosis, and quantification of the severity of sarcopenia in clinical. While functional measurements are more difficult to standardize and associated with higher variability, Dual-energy X-ray absorptiometry (DXA) is considered a highly accurate method, even referred to as the "gold standard" to determine muscle mass in the scientific literature. Nevertheless, DXA, which is routinely used, shows inconsistent correlation with functional decline in muscle strength. Another method of muscle quantification is bioelectrical impedance analysis (BIA), a simple, portable instrument that is more readily available and applicable due to its lower cost. However, it tends to overestimate muscle mass and is also more susceptible to a person's hydration status. Because of these difficulties, recent research has focused on the potential of using shear wave elastography. This method indirectly serves to quantify the rapid type II muscle fibers in order to make statements about the muscle quality because an age-related decrease in type II muscle fibers is associated with a more frequent fall frequency.
First, the investigators will define three different categories according to the EWGSOP 2 guidelines based on the muscle strength (grip strength, assessed by pneumatic hand dynamometer) and muscle mass (Appendicular skeletal muscle mass, assessed by BIA): "No Sarcopenia", "Probable Sarcopenia" and "Confirmed Sarcopenia". Within these categories, the Investigators would like to establish a multivariate data analysis of different functional measurements with quantitative imaging results. This exploratory trial design is intended to improve understanding within the three categories and to test proxy measurements of different patients who are ruled out for common routine measurements due to, for example, cognitive impairment or pre-existing rheumatic disease. This is essential to consider the heterogeneity of the aging society proportionally.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Anonymous. (2022). SARCOPEDIA - Sarcopenia Diagnostics in Aging Medicine. <em>University Department of Geriatric Medicine FELIX PLATTER</em>. https://clinicaltrials.gov/study/NCT05263596
Vancouver
Anonymous. SARCOPEDIA - Sarcopenia Diagnostics in Aging Medicine. University Department of Geriatric Medicine FELIX PLATTER. 2022.
BibTeX
@misc{anon2022SARCOP,
title = {SARCOPEDIA - Sarcopenia Diagnostics in Aging Medicine},
author = {Anonymous},
journal = {University Department of Geriatric Medicine FELIX PLATTER},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Gazi University 2026
Open access · US-GOV
Evaluation of the Relationship Between Fall Risk, Muscle Strength, and Anticholinergic Burden in Geriatric Patients Presenting to the Emergency Department
Springer eBooks 2010
Citation only
Sarcopenia – Age-Related Muscle Wasting and Weakness
University of Bedfordshire 2018
Open access · US-GOV
Can the Sit-to-Stand Test be Used as a Screening Tool to Detect Sarcopenia in Community-dwelling Older People?
Elsevier eBooks 2016
Citation only
The Aging Muscle and Sarcopenia
Elsevier eBooks 2019
Citation only
Aging Muscle and Sarcopenia
Journal of Diabetes Research 2020
Open access · CC-BY